Risk of subsequent neoplasms during the fifth and sixth decades of life in the childhood cancer survivor study cohort

Lucie M. Turcotte, John A. Whitton, Debra L. Friedman, Sue Hammond, Gregory T. Armstrong, Wendy Leisenring, Leslie L. Robison, Joseph P. Neglia

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Purpose: Survivors of childhood cancer have an increased risk for subsequent neoplasms (SNs), but the ncidence beyond the age of 40 years and associations with therapeutic exposures have not been well described Patients and Methods: Among 14,364 survivors of childhood cancer diagnosed between 1970 and 1986, 3,171 had an attained age of 40 years or older at the time of last contact. Cumulative incidence of SNs, standardized incidence ratios (SIRs), excess absolute risk of subsequent malignant neoplasms (SMNs), and relative risks (RRs) for SMNs and nonmelanoma skin cancers were calculated Results: In total, 679 SNs were diagnosed in patients age 40 years or older. These included 196 SMNs, 419 nonmelanoma skin cancers, 21 nonmalignant meningiomas, and 43 other benign neoplasms. At age 55 years, the cumulative incidence of new SNs and SMNs occurring after age 40 years was 34.6% (95% CI, 28.7 to 40.6) and 16.3% (95% CI, 11.7 to 20.9), respectively. Survivors were twice as likely as the general population to receive a diagnosis of SMN after age 40 years (SIR, 2.2; 95% CI, 1.9 to 2.5). Among SMNs, risk was increased for breast cancer (SIR, 5.5; 95% CI, 4.5 to 6.7), renal cancer (SIR, 3.9; 95% CI, 2.0 to 7.5), soft tissue sarcoma (SIR, 2.6; 95% CI, 1.5 to 4.4), and thyroid cancer (SIR, 1.9; 95% CI, 1.0 to 3.5). Female sex (RR, 1.9; 95% CI, 1.3 to 2.6; P< .001) and therapeutic radiation exposure (RR, 2.2; 95% CI, 1.4 to 3.3; P< .001) were associated with an increased for risk for SMN in multivariable analysis. Conclusion: Even after age 40 years, survivors of childhood cancer remain at increased risk for treatment-related SNs. These data suggest the need for life-long monitoring and should inform anticipatory guidance provided to survivors of childhood cancer.

Original languageEnglish (US)
Pages (from-to)3568-3575
Number of pages8
JournalJournal of Clinical Oncology
Volume33
Issue number31
DOIs
StatePublished - Nov 1 2015

Fingerprint

Survivors
Cohort Studies
Neoplasms
Incidence
Skin Neoplasms
Second Primary Neoplasms
Kidney Neoplasms
Meningioma
Thyroid Neoplasms
Sarcoma

Cite this

Risk of subsequent neoplasms during the fifth and sixth decades of life in the childhood cancer survivor study cohort. / Turcotte, Lucie M.; Whitton, John A.; Friedman, Debra L.; Hammond, Sue; Armstrong, Gregory T.; Leisenring, Wendy; Robison, Leslie L.; Neglia, Joseph P.

In: Journal of Clinical Oncology, Vol. 33, No. 31, 01.11.2015, p. 3568-3575.

Research output: Contribution to journalArticle

Turcotte, Lucie M. ; Whitton, John A. ; Friedman, Debra L. ; Hammond, Sue ; Armstrong, Gregory T. ; Leisenring, Wendy ; Robison, Leslie L. ; Neglia, Joseph P. / Risk of subsequent neoplasms during the fifth and sixth decades of life in the childhood cancer survivor study cohort. In: Journal of Clinical Oncology. 2015 ; Vol. 33, No. 31. pp. 3568-3575.
@article{bbb75b754f3a4433b740378d38239475,
title = "Risk of subsequent neoplasms during the fifth and sixth decades of life in the childhood cancer survivor study cohort",
abstract = "Purpose: Survivors of childhood cancer have an increased risk for subsequent neoplasms (SNs), but the ncidence beyond the age of 40 years and associations with therapeutic exposures have not been well described Patients and Methods: Among 14,364 survivors of childhood cancer diagnosed between 1970 and 1986, 3,171 had an attained age of 40 years or older at the time of last contact. Cumulative incidence of SNs, standardized incidence ratios (SIRs), excess absolute risk of subsequent malignant neoplasms (SMNs), and relative risks (RRs) for SMNs and nonmelanoma skin cancers were calculated Results: In total, 679 SNs were diagnosed in patients age 40 years or older. These included 196 SMNs, 419 nonmelanoma skin cancers, 21 nonmalignant meningiomas, and 43 other benign neoplasms. At age 55 years, the cumulative incidence of new SNs and SMNs occurring after age 40 years was 34.6{\%} (95{\%} CI, 28.7 to 40.6) and 16.3{\%} (95{\%} CI, 11.7 to 20.9), respectively. Survivors were twice as likely as the general population to receive a diagnosis of SMN after age 40 years (SIR, 2.2; 95{\%} CI, 1.9 to 2.5). Among SMNs, risk was increased for breast cancer (SIR, 5.5; 95{\%} CI, 4.5 to 6.7), renal cancer (SIR, 3.9; 95{\%} CI, 2.0 to 7.5), soft tissue sarcoma (SIR, 2.6; 95{\%} CI, 1.5 to 4.4), and thyroid cancer (SIR, 1.9; 95{\%} CI, 1.0 to 3.5). Female sex (RR, 1.9; 95{\%} CI, 1.3 to 2.6; P< .001) and therapeutic radiation exposure (RR, 2.2; 95{\%} CI, 1.4 to 3.3; P< .001) were associated with an increased for risk for SMN in multivariable analysis. Conclusion: Even after age 40 years, survivors of childhood cancer remain at increased risk for treatment-related SNs. These data suggest the need for life-long monitoring and should inform anticipatory guidance provided to survivors of childhood cancer.",
author = "Turcotte, {Lucie M.} and Whitton, {John A.} and Friedman, {Debra L.} and Sue Hammond and Armstrong, {Gregory T.} and Wendy Leisenring and Robison, {Leslie L.} and Neglia, {Joseph P.}",
year = "2015",
month = "11",
day = "1",
doi = "10.1200/JCO.2015.60.9487",
language = "English (US)",
volume = "33",
pages = "3568--3575",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "31",

}

TY - JOUR

T1 - Risk of subsequent neoplasms during the fifth and sixth decades of life in the childhood cancer survivor study cohort

AU - Turcotte, Lucie M.

AU - Whitton, John A.

AU - Friedman, Debra L.

AU - Hammond, Sue

AU - Armstrong, Gregory T.

AU - Leisenring, Wendy

AU - Robison, Leslie L.

AU - Neglia, Joseph P.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Purpose: Survivors of childhood cancer have an increased risk for subsequent neoplasms (SNs), but the ncidence beyond the age of 40 years and associations with therapeutic exposures have not been well described Patients and Methods: Among 14,364 survivors of childhood cancer diagnosed between 1970 and 1986, 3,171 had an attained age of 40 years or older at the time of last contact. Cumulative incidence of SNs, standardized incidence ratios (SIRs), excess absolute risk of subsequent malignant neoplasms (SMNs), and relative risks (RRs) for SMNs and nonmelanoma skin cancers were calculated Results: In total, 679 SNs were diagnosed in patients age 40 years or older. These included 196 SMNs, 419 nonmelanoma skin cancers, 21 nonmalignant meningiomas, and 43 other benign neoplasms. At age 55 years, the cumulative incidence of new SNs and SMNs occurring after age 40 years was 34.6% (95% CI, 28.7 to 40.6) and 16.3% (95% CI, 11.7 to 20.9), respectively. Survivors were twice as likely as the general population to receive a diagnosis of SMN after age 40 years (SIR, 2.2; 95% CI, 1.9 to 2.5). Among SMNs, risk was increased for breast cancer (SIR, 5.5; 95% CI, 4.5 to 6.7), renal cancer (SIR, 3.9; 95% CI, 2.0 to 7.5), soft tissue sarcoma (SIR, 2.6; 95% CI, 1.5 to 4.4), and thyroid cancer (SIR, 1.9; 95% CI, 1.0 to 3.5). Female sex (RR, 1.9; 95% CI, 1.3 to 2.6; P< .001) and therapeutic radiation exposure (RR, 2.2; 95% CI, 1.4 to 3.3; P< .001) were associated with an increased for risk for SMN in multivariable analysis. Conclusion: Even after age 40 years, survivors of childhood cancer remain at increased risk for treatment-related SNs. These data suggest the need for life-long monitoring and should inform anticipatory guidance provided to survivors of childhood cancer.

AB - Purpose: Survivors of childhood cancer have an increased risk for subsequent neoplasms (SNs), but the ncidence beyond the age of 40 years and associations with therapeutic exposures have not been well described Patients and Methods: Among 14,364 survivors of childhood cancer diagnosed between 1970 and 1986, 3,171 had an attained age of 40 years or older at the time of last contact. Cumulative incidence of SNs, standardized incidence ratios (SIRs), excess absolute risk of subsequent malignant neoplasms (SMNs), and relative risks (RRs) for SMNs and nonmelanoma skin cancers were calculated Results: In total, 679 SNs were diagnosed in patients age 40 years or older. These included 196 SMNs, 419 nonmelanoma skin cancers, 21 nonmalignant meningiomas, and 43 other benign neoplasms. At age 55 years, the cumulative incidence of new SNs and SMNs occurring after age 40 years was 34.6% (95% CI, 28.7 to 40.6) and 16.3% (95% CI, 11.7 to 20.9), respectively. Survivors were twice as likely as the general population to receive a diagnosis of SMN after age 40 years (SIR, 2.2; 95% CI, 1.9 to 2.5). Among SMNs, risk was increased for breast cancer (SIR, 5.5; 95% CI, 4.5 to 6.7), renal cancer (SIR, 3.9; 95% CI, 2.0 to 7.5), soft tissue sarcoma (SIR, 2.6; 95% CI, 1.5 to 4.4), and thyroid cancer (SIR, 1.9; 95% CI, 1.0 to 3.5). Female sex (RR, 1.9; 95% CI, 1.3 to 2.6; P< .001) and therapeutic radiation exposure (RR, 2.2; 95% CI, 1.4 to 3.3; P< .001) were associated with an increased for risk for SMN in multivariable analysis. Conclusion: Even after age 40 years, survivors of childhood cancer remain at increased risk for treatment-related SNs. These data suggest the need for life-long monitoring and should inform anticipatory guidance provided to survivors of childhood cancer.

UR - http://www.scopus.com/inward/record.url?scp=84947242835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947242835&partnerID=8YFLogxK

U2 - 10.1200/JCO.2015.60.9487

DO - 10.1200/JCO.2015.60.9487

M3 - Article

C2 - 26261260

AN - SCOPUS:84947242835

VL - 33

SP - 3568

EP - 3575

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 31

ER -